Bioqual (BIOQ) Stock Analysis & Winston Score

Bioqual, Inc. is a contract research organization (CRO) that runs animal studies for drug and vaccine developers. Scientists and pharmaceutical companies hire Bioqual to test whether new medicines are safe and effective before those medicines move into human clinical trials. The company specializes in non-human primate research, which is considered a critical step in developing vaccines for diseases like HIV, COVID-19, and Ebola.

Bioqual earns money by charging clients fees for conducting these preclinical studies at its research facilities, primarily located in the United States. It is a small company with a market cap near zero, meaning it is very early-stage or thinly traded. Its main competitive edge is its specialized expertise with non-human primates, which are expensive and difficult to work with, creating a narrow but real barrier to entry. The biggest risk the company faces is its negative gross margin, which means it currently costs more to deliver its services than it earns from them, raising questions about its path to profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-29.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-180.0% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.4%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$11M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Bioqual's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

1.1%

Thin — 1.1% gross margin

Operating Margin

-12.6%

Losing money on operations — -12.6%

ROCE

-3.3%

Weak — -3.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-3.9%

Shrinking sales (-3.9% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-6.7%

Burning cash (-6.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.09

Conservative — low debt load (0.09)

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial